Posted Dec. 18, 2013 at 1:50 p.m.

Premium Lock COPD drug from GSK, Theravance gets FDA approval

Published: 2013-12-18 13:50:49
Updated: 2013-12-18 13:50:49

Lung disease Lung disease Image 1 of 2 · Next Image…

GlaxoSmithKline and Theravance received FDA approval on Anoro Ellipta, a drug indicated for treating chronic obstructive pulmonary disease (COPD). Read more about the drug and GSK's launch plans....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders